MAAT INDEX

CLAIM #56132 · Thermo Fisher Scientific Inc (TMO) · 2022Q1 earnings call · Apr 28, 2022 · due Dec 31, 2022

And we now estimate that the full year average diluted share count will be between 394 million and 395 million shares.

Stephen Williamson · CFO

PENDING
graded after results covering Dec 31, 2022 are reported

How to check this claim

Look at: Full year average diluted share count, fiscal 2022

It came true if: Between 394 million and 395 million shares

Where: Company 10-K / Q4 2022 earnings release (diluted shares used in EPS calculation)

In context

sted operating income in 2022 and contribute a $1.98 to adjusted EPS in the year up $0.08 from our prior guidance. FX is now expected to be a year-over-year headwind of $700 million on revenue, or 1.8% and $0.54 on adjusted EPS. We continue to expect net interest expense of approximately $490 million for the year. We now expect an adjusted income tax rate of 13.1% in 2022, slightly higher than the prior guide driven by the improved earnings outlook. We continue to assume net capital expenditures of approximately $2.5 billion to $2.7 billion and free cash flow of approximately $7 billion. A guidance still assumes $2.5 billion of capital deployment, which is the $2 billion of share buybacks that we completed in January and $475 million of capital to return to shareholders through dividends. And we now estimate that the full year average diluted share count will be between 394 million and 395 million shares. And finally, a couple of comments on phasing to help you with your modeling, revenue dollars for the remainder of the year they're expected to be fairly linear with Q4 being slightly higher than Q2 and Q3. Core organic growth for Q2 is expected to be lower than Q3 and Q4 due to an estimated 200 basis point impact of lockdowns in China. And in terms of adjusted EPS phasing, we expect Q2 as a percentage of the full year to be just slightly lower than the comparable periods last year. To conclude we'd live an excellent start to the year, and we're in a great position to achieve our 2022 goals. With that, I'll turn the call back over to Raf. Rafael Tejada: Thank you, Stephen. Operator, we're ready to take questions. Operator: Thank you. [Operator Instructions] And our first question today com

Verify independently

SEC filings for TMO · Claim quote is verbatim from the 2022Q1 earnings call.